The paper:
- highlights the significance of policy on pharmaceutical pricing, given increasing costs and spending on medicines as part of overall healthcare spending in Canada;
- identifies recent developments that are important because they inform current debates in Canada over regulating drug prices, or our policies in general relating to pharmaceuticals;
- outlines current federal law and policy on the regulation of pharmaceutical manufacturers’ prices; and, finally,
- makes recommendations for reform of federal regulation of pharmaceutical prices in Canada.